Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China
· Delayed Price · Currency is CNY 27.90
-0.50 (-1.76%)
At close: Mar 9, 2026
SHA:603983 Revenue
Guangdong Marubi Biotechnology had revenue of 681.19M CNY in the quarter ending September 30, 2025, with 13.52% growth. This brings the company's revenue in the last twelve months to 3.47B, up 31.28% year-over-year. In the year 2024, Guangdong Marubi Biotechnology had annual revenue of 2.97B with 33.44% growth.
Revenue (ttm)
3.47B
Revenue Growth
+31.28%
P/S Ratio
3.23
Revenue / Employee
2.93M
Employees
1,185
Market Cap
11.19B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| C&S Paper Co.,Ltd | 8.67B |
| Shanghai Jahwa United | 6.16B |
| Runben Biotechnology | 1.52B |
| Shanghai Flyco Electrical Appliance | 3.87B |
| Chongqing Baiya Sanitary Products | 3.55B |
| Yunnan Botanee Bio-Technology Group Co.LTD | 5.18B |
| Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou | 1.98B |
| Hangzhou Haoyue Personal Care | 3.61B |